Valerie Durkalski-Mauldin to Treatment Outcome
This is a "connection" page, showing publications Valerie Durkalski-Mauldin has written about Treatment Outcome.
Connection Strength
0.174
-
Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization. J Biopharm Stat. 2020; 30(1):69-88.
Score: 0.071
-
Convalescent Plasma for Outpatients with Covid-19. Reply. N Engl J Med. 2021 12 02; 385(23):2206-2207.
Score: 0.021
-
Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286.
Score: 0.019
-
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 07 23; 322(4):326-335.
Score: 0.018
-
Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study. Am J Med Sci. 2018 Jun; 355(6):537-543.
Score: 0.016
-
Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9.
Score: 0.015
-
Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015 Feb; 56(2):254-62.
Score: 0.013